NextCure, Inc.

NasdaqGS:NXTC 株式レポート

時価総額:US$43.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

NextCure マネジメント

マネジメント 基準チェック /34

NextCure'sの CEO はMichael Richmanで、 Oct2015年に任命され、 の在任期間は 8.67年です。 の年間総報酬は$ 1.04Mで、 54.7%給与と45.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の1.45%を直接所有しており、その価値は$ 581.05K 。経営陣と取締役会の平均在任期間はそれぞれ3.4年と5.2年です。

主要情報

Michael Richman

最高経営責任者

US$1.0m

報酬総額

CEO給与比率54.7%
CEO在任期間8.8yrs
CEOの所有権1.5%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Mar 23
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Dec 09
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?

Aug 23
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?

Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?

May 10
Is NextCure (NASDAQ:NXTC) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Nov 22
We're Keeping An Eye On NextCure's (NASDAQ:NXTC) Cash Burn Rate

Estimating The Intrinsic Value Of NextCure, Inc. (NASDAQ:NXTC)

Aug 09
Estimating The Intrinsic Value Of NextCure, Inc. (NASDAQ:NXTC)

NextCure GAAP EPS of -$0.59

Aug 04

We're Not Very Worried About NextCure's (NASDAQ:NXTC) Cash Burn Rate

May 02
We're Not Very Worried About NextCure's (NASDAQ:NXTC) Cash Burn Rate

NextCure: Large Upside With Downside Protected By Cash Pile

Sep 29

NextCure (NXTC) Presents at 7th Annual Truist Securities Life Sciences Summit - Slideshow

May 10

NextCure EPS misses by $0.01

May 06

Here's What NextCure, Inc.'s (NASDAQ:NXTC) Shareholder Ownership Structure Looks Like

Feb 12
Here's What NextCure, Inc.'s (NASDAQ:NXTC) Shareholder Ownership Structure Looks Like

NextCure's (NASDAQ:NXTC) Shareholders Are Down 80% On Their Shares

Jan 08
NextCure's (NASDAQ:NXTC) Shareholders Are Down 80% On Their Shares

NextCure provides update on NC318 clinical program

Dec 17

CEO報酬分析

NextCure の収益と比較して、Michael Richman の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$64m

Dec 31 2023US$1mUS$572k

-US$63m

Sep 30 2023n/an/a

-US$66m

Jun 30 2023n/an/a

-US$70m

Mar 31 2023n/an/a

-US$70m

Dec 31 2022US$2mUS$549k

-US$75m

Sep 30 2022n/an/a

-US$74m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$3mUS$529k

-US$69m

Sep 30 2021n/an/a

-US$68m

Jun 30 2021n/an/a

-US$66m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$6mUS$491k

-US$37m

Sep 30 2020n/an/a

-US$32m

Jun 30 2020n/an/a

-US$24m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$626kUS$419k

-US$34m

Sep 30 2019n/an/a

-US$30m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$24m

Dec 31 2018US$3mUS$383k

-US$23m

報酬と市場: Michaelの 総報酬 ($USD 1.04M ) は、 US市場 ($USD 673.68K ) の同規模の企業の平均を上回っています。

報酬と収益: Michaelの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Michael Richman (63 yo)

8.8yrs

在職期間

US$1,044,627

報酬

Mr. Michael S. Richman, MSBA, Co-founded NextCure, Inc. since 2015 and has been its Chief Executive Officer, President & Director since July 2015. Mr. Richman served as the Chief Executive Officer and Pres...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Michael Richman
Co-Founder8.8yrsUS$1.04m1.45%
$ 637.9k
Solomon Langermann
Chief Scientific Officer5.6yrsUS$681.59k0.13%
$ 58.6k
Han Myint
Chief Medical Officer3.5yrsUS$697.93k0%
$ 0
Lieping Chen
Co-Founder & Chairman of Scientific Advisory Board9.5yrsデータなしデータなし
Steven Cobourn
Chief Financial Officer6.5yrsUS$1.01mデータなし
Timothy Mayer
Chief Operating Officer4.8yrsデータなしデータなし
Kevin Shaw
Senior VP & General Counsel2.2yrsデータなしデータなし
Stacy Rollinger
Vice President of Human Resourcesless than a yearデータなしデータなし
Sourav Kundu
Senior Vice President of Development & Manufacturing3yrsデータなしデータなし
Sebastien Maloveste
Senior Vice President of Business Developmentless than a yearデータなしデータなし
Udayan Guha
Senior Vice President of Clinical & Translational Developmentless than a yearデータなしデータなし

3.5yrs

平均在職期間

63yo

平均年齢

経験豊富な経営陣: NXTCの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Michael Richman
Co-Founder8.8yrsUS$1.04m1.45%
$ 637.9k
Lieping Chen
Co-Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
Elaine Jones
Independent Director8.6yrsUS$67.47k0%
$ 0
Mario Sznol
Member of Scientific Advisory Boardno dataデータなしデータなし
David Kabakoff
Independent Chairman of the Board8.6yrsUS$93.16k0.22%
$ 97.7k
Stephen Webster
Independent Director5.3yrsUS$71.66k0%
$ 0
Ellen Feigal
Independent Director2.8yrsUS$61.66k0%
$ 0
Stephen Miller
Member of Scientific Advisory Boardno dataデータなしデータなし
John Houston
Independent Director3.8yrsUS$61.66k0%
$ 0
Weiping Zou
Member of Scientific Advisory Board2.8yrsデータなしデータなし
Ursula Matulonis
Member of Scientific Advisory Board2.8yrsデータなしデータなし
Anne Borgman-Hagey
Independent Director2.8yrsUS$60.66k0%
$ 0

3.8yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: NXTCの 取締役会経験豊富 であると考えられます ( 5.2年の平均在任期間)。